The Eph family of receptor tyrosine kinases regulates numerous biological processes. To examine the biochemical and developmental contributions of specific structural motifs within Eph receptors, wild-type or mutant forms of the EphA4 receptor were ectopically expressed in developing Xenopus embryos. Wild-type EphA4 and a mutant lacking both the SAM domain and PDZ binding motif were constitutively tyrosine phosphorylated in vivo and catalytically active in vitro. EphA4 induced loss of cell adhesion, ventro-lateral protrusions, and severely expanded posterior structures in Xenopus embryos. Moreover, mutation of a conserved SAM domain tyrosine to phenylalanine (Y928F) enhanced the ability of EphA4 to induce these phenotypes, suggesting that the SAM domain may negatively regulate some aspects of EphA4 activity in Xenopus. Analysis of double mutants revealed that the Y928F EphA4 phenotypes were dependent on kinase activity; juxtamembrane sites of tyrosine phosphorylation and SH2 domain-binding were required for cell dissociation, but not for posterior protrusions. The induction of protrusions and expansion of posterior structures is similar to phenotypic effects observed in Xenopus embryos expressing activated FGFR1. Furthermore, the budding ectopic protrusions induced by EphA4 express FGF-8, FGFR1, and FGFR4a. In addition, antisense morpholino oligonucleotide-mediated loss of FGF-8 expression in vivo substantially reduced the phenotypic effects in EphA4Y928F expressing embryos, suggesting a connection between Eph and FGF signaling.
INTRODUCTION
During embryonic development, Eph receptor tyrosine kinases (RTKs) and their activating ligands, termed ephrins, control numerous developmental processes such as neural crest cell migration , axon pathfinding , hindbrain segmentation (Xu et al., 1995) , angiogenesis (Wang et al., 1998) , and somitogenesis (Durbin et al., 1998) . Interaction of Eph receptors with ephrins can activate bidirectional signaling pathways (Holland et al., 1996; Davy et al., 1999) , frequently resulting in repulsive cell-cell signaling . Eph receptors are characterized by an extracellular region, containing an N-terminal ephrin-binding domain, a cysteine-rich region, and two fibronectin type III repeats, and a cytoplasmic sequence comprising a juxtamembrane regulatory element, a tyrosine kinase domain, a SAM (sterile alpha motif) domain, and a C-terminal PDZ (post synaptic density protein, disk large, zona occludens) binding motif.
On ephrin binding, Eph receptors autophosphorylate on tyrosine residues that both regulate kinase activity and serve as binding sites for cytoplasmic target proteins (reviewed by Kalo and Pasquale, 1999b) . Several in vitro and in vivo tyrosine phosphorylation sites have been identified that reside within the juxtamembrane region, the kinase domain, and the SAM domain (Kalo and Pasquale, 1999a) . Two conserved tyrosine residues in the juxtamembrane region repress the intrinsic kinase activity of EphA4 and EphB2 in their unphosphorylated state (Binns et al., 2000; Zisch et al., 2000; Wybenga-Groot et al., 2001) . Autophosphorylation of these juxtamembrane tyrosines concomitantly stimulates kinase activity and creates binding sites for SH2-containing targets such as Abl, Arg, Fyn, Nck1, Ras GAP, Src, SLAP, and SHEP1 (Pandey et al., 1995; Ellis et al., 1996; Holland et al., 1997; Zisch et al., 1998; Dodelet et al., 1999; Yu et al., 2001) . Autophosphorylation within the kinase domain activation segment potentiates Eph kinase activity. Furthermore, a conserved tyrosine residue within the SAM domain of EphB1 has been suggested to recruit signaling molecules such as Grb10 and the low-molecular-weight protein tyrosine phosphatase (Stein et al., 1996 (Stein et al., , 1998 . The SAM domains of Eph receptors can self-associate to form dimers or oligomers (Smalla et al., 1999; Stapleton et al., 1999; Thanos et al., 1999) , but their functional role has remained obscure (Gu and Park, 2001) . Indeed, despite being highly conserved, the SAM domain appears entirely dispensable in the context of EphA4 signaling in the mouse (Kullander et al., 2001) .
During Xenopus development, expression of EphA4 (Pagliaccio/Sek-1) begins early in gastrulation and continues through to the tadpole stage. EphA4 expression is observed in the forebrain, olfactory placode, hindbrain (r3 and r5), otic placode, third visceral arch, and pronephros (Winning and Sargent, 1994; Xu et al., 1995) . Ectopic expression of dominant negative EphA4 in Xenopus induces abnormal boundary formation in the hindbrain (Xu et al., 1995) and inappropriate migration of branchial neural crest cells . Stimulation of a chimeric EGFR/EphA4 receptor results in a loss of cell adhesion and disrupts polarity during early Xenopus development (Winning et al., 1996 (Winning et al., , 2001 .
To pursue the functional contributions of specific Eph domains and motifs to signaling in an in vivo system, we examined the effect of overexpressing wild-type (WT) and mutant forms of EphA4 during Xenopus development. Here we show that EphA4 receptors harboring a deletion of the SAM domain, or mutation of tyrosine 928 contained within this domain, continue to display tyrosine kinase activity and induce ectopic protruding structures during Xenopus embryogenesis, which is dependent on FGF signaling. Moreover, we have exploited this system to explore the in vivo functions of Eph-mediated phosphorylation and protein-protein interactions.
MATERIALS AND METHODS

Molecular Cloning and Mutagenesis
Mouse EphA4 cDNA was obtained from Regeneron (Tarrytown, NY). XbaI sites were added to the 5Ј and 3Ј end of the EphA4 cDNA using PCR and subcloned into the XbaI site of the Xenopus expression vector, pCS2
ϩ . Desired mutations were introduced using a QuikChange site-directed mutagenesis strategy (Stratagene, La Jolla, CA) and were confirmed by DNA sequence analysis. Deletion of the globular domain (amino acid 33-202) and addition of the N-terminal Flag tag (DYKDDDDK) were conducted by PCR. Full-length Xenopus FGF-8 cDNA was isolated by PCR using a Xenopus stage 30 head cDNA library (a gift from R. Harland), and then sequenced. An HA-tag (YPYDVPDYA) was introduced at the C-termini of both FGF-8a and FGF-8b by PCR and cloned into BamHI and EcoRI sites of pCS2 ϩ .
Preparation of Xenopus Embryos, Synthetic RNA, Lineage Trace, and Animal Cap Explants
Embryos were obtained by artificial insemination after induction of females with 500 IU of human chorionic gonadotropin (Sigma, St. Louis, MO). Capped mRNA was made using the SP6 mMessage mMachine kit (Ambion, Austin, TX). pCS2 ϩ plasmids containing EphA4 constructs, ␤-galactosidase, FGFR1K562E (an activated FGFR1, a gift from R. Friesel) and HA-tagged FGF-8a and FGF-8b were linearized with NotI. Control, FGF-8-AS (5Ј-CCA GGA TGG AGG TGA TGT AGT TCA T) and FGF-8-AS-4PM (5Ј-CCA GGA TGG AGG TCA TCT ACT TGA T) morpholino oligonucleotides were obtained from Gene Tools, LLC (Corvallis, OR). Embryos were injected into both blastomeres at the two-cell stage with indicated amounts of RNAs or antisense morpholino oligonucleotides. Lineage tracing was performed by ␤-galactosidase staining as previously described (Sive et al., 2000) . Briefly, Xenopus embryos injected with 200 pg of ␤-gal mRNA at the two-cell stage were cultured until stage 30 and then rinsed with 0.7ϫ phosphate-buffered saline (PBS), and fixed for 1 h on ice in freshly prepared 0.7ϫ PBS containing 2% formaldehyde, 0.2% glutaraldehyde, 0.02% Triton X-100, and 0.01% sodium deoxycholate. Embryos were rinsed twice with 0.7ϫ PBS and stained at 30°C in 0.7ϫ PBS containing 5 mM K 3 Fe(CN) 6 , 5 mM K 4 Fe(CN) 6 , 1 mg/ml X-gal, and 1 mM MgCl 2 . Embryos were fixed in MEMPFA for 1 h and photographed with a Nikon CCD camera (Garden City, NY). Animal cap explants were made using forceps or the Gastromaster (Xenotek Engineering, Belleville, IL) at stage 8. The explants were cultured as described previously (Maeda et al., 2001) .
Whole Mount In Situ Hybridization
Plasmids containing cDNAs were obtained and linearized, and digoxygeninlabeled riboprobes were synthesized using MegaScript kit (Ambion) as specified: Xenopus Ap-2 (T. Sargent, HindIII, T7 polymerase), Nrp-1 (I. Dawid, BamHI, T3 polymerase), Xpo (T. Sargent, PstI, T7 polymerase), Xhox-3 (J. Howard, DdeI, T7 polymerase), Xslug (M. Sargent, BglII, SP6 polymerase), ADAM13 (D. DeSimone, XhoI, T3 polymerase), FGF-8 (J. Slack, XbaI, T3 polymerase), FGFR1 (R. Friesel, NcoI, T7 polymerase), and Xenopus EphA4 (A. Brandli, BamHI, T7 polymerase). A ClaI/XhoI fragment from pSP64Xwnt3a (R. Moon) was subcloned into pBluscript SK ϩ and linearized with ClaI, and the riboprobe was synthesized with T7 polymerase. A KpnI/SalI fragment from pSP64TXFGFR4a (I. Hongo and H. Okamoto) was subcloned into pBluscript SK ϩ and linearized with KpnI, and T3 polymerase was used to synthesize the riboprobe. Whole mount in situ hybridization was essentially done as described by Harland with modification (Maeda et al., 2001) . For detection, BM Purple (Roche, Indianapolis, IN) was used as a chromogenic substrate. The reaction was stopped and the embryos were refixed in MEMPFA (0.1 M MOPS [pH 7.4], 2 mM EGTA, 1 mM MgSO 4 , and 4% paraformaldehyde) for 1 h. When pigmented embryos were used, embryos were bleached with a solution containing 1% H 2 O 2 , 5% formamide, and 0.5ϫ SSC after staining (Mayor et al., 1995) .
RT-PCR Assay
Total RNA from animal cap explants and staged embryos was extracted using Trizol (Life Technologies, Rockville, MD). cDNA was synthesized from 1 g total RNA using SuperScriptII (Life Technologies). PCR was performed in 50 l containing 1 l of cDNA, 1ϫ Taq buffer, 1.5 mM MgCl 2 , 0.2 mM each of dNTPs, 350 ng of each primer, and 1 U of AmpliTaq DNA polymerase (Perkin-Elmer Cetus, Norwalk, CT). Primers and cycle number used for FGF-8 were as follows: forward, 5Ј-CAC CTC CAT CCT GGG CTA TCT G and reverse, 5Ј-GAT TAA CTT GGC GTG TGG GTC for 27 cycles at 64°C annealing temperature. Primers and PCR condition for eFGF were as follows: forward, 5Ј-CGG GTT TCA TAT CCA GGT TTT AC and reverse, 5Ј-GCG TTA TAG TTG TTG GGC AGA AG for 29 cycles at 62°C. The primer sequences and conditions for NCAM, Otx-2, Krox-20, HoxB9, muscle actin, and EF-1␣ have been previously published (Hemmati-Brivanlou and Melton, 1994) . Xtwist primer sequences were posted at the Xenbase web page: www.xenbase.org/ genomics/genomics.html.
Immunoprecipitation and Western Blot Analysis
Embryos were prepared with ice-cold lysis buffer (20 mM Tris [pH 8.0], 150 mM NaCl, 1% Nonidet P-40 containing 1:50 diluted Protease Inhibitor Cocktail Set III, Calbiochem, La Jolla, CA), as previously described (Chong et al., 2000) , followed by extraction with Freon (Sigma) at a 1:1 (vol/vol) ratio. IPs were conducted on 10 embryo equivalents with antibody raised against phosphotyrosine (4G10, UBI) or EphA4 (a rabbit polyclonal antibody raised against peptide: VLEDDPEAAYTTRG) for 4 h or overnight and protein-A/G agarose (Santa Cruz Biotechnology, Santa Cruz, CA) for an additional 1 h. After three washes with lysis buffer, IPs were separated by SDS-PAGE. The proteins were transferred to a membrane (Immobilon-P, Millipore, Bedford, MA), blocked with 5% nonfat dry milk in TBS containing 0.1% Tween-20 (TBST), and incubated with anti-Sek1/EphA4 (Transduction Laboratories, Lexington, KY). For antiphosphotyrosine blotting, 5% BSA in TBST was used to block. Proteins were visualized using an appropriate secondary antibody coupled to HRP (UBI, Lake Placid, NY), followed by application of enhanced chemiluminescence reagents (Amersham, Piscataway, NJ).
In Vitro Kinase Assays
EphA4 IPs were washed three times with HNTG Buffer (20 mM HEPES [pH 7.5], 150 mM NaCl, 10% glycerol, 0.1% Triton X-100, 100 M sodium vanadate) and twice more with kinase buffer (25 mM HEPES [pH 7.5], 2.5 mM MgCl 2 , 4 mM MnCl 2 , 100 M sodium vanadate). Ten percent of each sample was used for Western blot analysis to confirm equal levels of expression, and the remaining sample was incubated in kinase buffer containing 5 g of acid denatured Enolase (Sigma) and 5 Ci of [␥-32 P]ATP at room temperature for 30 min. The reaction was stopped by adding SDS/PAGE sample buffer and heating to 100°C. The reaction products were resolved using SDS polyacrylamide (10%) gels and subsequently stained, destained, and dried before autoradiography.
RESULTS
The SAM Domain Does Not Contribute to EphA4 Activity In Vitro, But Displays Negative Regulation In Vivo
To explore the functional effect of specific Eph motifs in vivo, we expressed WT and mutant forms of mouse EphA4 in Xenopus embryos. In particular, we examined the effects of mutating the SAM domain, the kinase domain, and tyrosine autophosphorylation sites in the juxtamembrane region and the SAM domain ( Figure 1A ). mRNAs (2.5 ng/embryo) encoding WT or mutant receptors were injected into the animal pole of two-cell stage embryos in the absence of exogenous ligand. Embryos were harvested at stage 9 to examine the phosphorylation state of the receptor. At this stage of development, the WT receptor displayed in vitro kinase activity and was significantly tyrosine phosphorylated in vivo ( Figure 1 , B and C). Kinase dead forms of the receptor with mutations in the kinase domain or juxtamem-brane tyrosines were inactive in vitro and were not significantly tyrosine phosphorylated in vivo ( Figure 1 , B and C). In contrast, the ⌬SAM EphA4 mutant lacking both the SAM domain and PDZ binding motif was tyrosine phosphorylated in Xenopus embryos and showed significant in vitro kinase activity ( Figure 1 , B and C). These results suggest that neither the SAM domain nor the PDZ domain is essential for EphA4 kinase activity in Xenopus embryos.
To further examine the role of the SAM domain in activating EphA4, individual residues within the SAM domain were mutated. Mutation of a conserved SAM domain tyrosine residue, a potential site for phosphorylation and binding to cytoplasmic proteins, to either Phe or Glu resulted in robust EphA4 tyrosine phosphorylation in vivo and kinase activity in vitro ( Figure 1 , B and C). Sequence alignments show that this tyrosine residue is present in all Eph SAM domains, with the exception of EphA3 paralogs. These data suggest that the SAM domain may normally exert an inhibitory effect on EphA4 activity, at least in the context of the developing Xenopus embryo.
EphA4 and SAM Domain Mutants Induce Ectopic Posterior Structures
WT and Y928F EphA4 expressing embryos developed ectopic protrusions that evaginate from the posterior region beginning at the neurula stage ( Figure 2A ). In situ hybridization reveals that these ectopic protrusions express the posterior marker, Xpo ( Figure 2A ). Furthermore, the Y928F mutant induced these posterior protrusions at a frequency 2.5 times that of WT, despite being expressed at equal levels ( Figure 2 , B and C). These protruding structures were formed from a subset of the tissue expressing Y928F as evidenced by lineage tracing via coexpression of ␤-galactosidase ( Figure 2D ). Thus, the Y928F mutant was used in subsequent experiments. Embryos injected with RNA encoding the wild-type EphA4, Y928F EphA4, or ⌬SAM EphA4 mutants (hereafter referred to as WT, Y928F, and ⌬SAM, respectively) displayed a dramatic loss of cell adhesion at the blastula stage, whereas embryos expressing KD mutants were similar to uninjected controls ( Figure 3A and unpublished data). This result is consistent with a previous report that an EGFR/EphA4 chimera stimulated with TGF-␣ leads to cell dissociation in Xenopus embryos (Winning et al., 1996) . As development proceeded to the tadpole stage, taillike structures evolved from these protrusions ( Figure 3A ) and whole mount in situ hybridizations of 1-day embryos showed expression of the posterior markers Xpo, Xwnt3a, and Xhox-3 (Ruiz i Altaba and Melton, 1989; Sato and Sargent, 1991; Wolda et al., 1993; Slack, 1998, 1999; Figures 2A and 3B) . These results confirm that Y928F-induced protrusions display posterior molecular characteristics. A truncated EphA4 receptor has previously been shown to induce inappropriate migration of branchial neural crest cells . We examined the expression of neural and neural crest markers in Y928F embryos and found normal neural crest patterning was disrupted as evidenced by the neural crest markers, Xslug and Xap-2 ( Figure 3B , open arrows). These two markers (Winning et al., 1991; Mayor et al., 1995) were robustly expressed in the protrusions of Y928F expressing embryos ( Figure 3B , filled arrows). Taken together, these results suggest that Y928F can induce ectopic protrusions that display both posterior and neural crest molecular characteristics. Although such markers were induced in embryos in vivo, Y928F failed to directly induce posterior neural tissue in naïve ectodermal explants and failed to promote a more caudal fate in neuralized explants in vitro, suggesting that the activated EphA4 receptor does not alter cell fate in explants (unpublished data).
Other EphA4 Motifs and Domains Are Required for the Phenotype Induced by Y928F
We used the Y928F mutant to explore motifs and domains required in a positive manner for Eph receptor signaling by engineering additional mutations into the Y928F receptor (Figure 4A) . mRNAs (2.5 ng/embryo) encoding these double mutants were injected into the animal pole of two-cell stage embryos. EphA4 kinase activity and the consequent binding of SH2 domain proteins to the EphA4 juxtamembrane autophosphorylation sites could potentially play a role in inducing the phenotypes observed in Y928F expressing embryos. Mutating the two regulatory juxtamembrane tyrosines to phenylalanine (Y928FY596/602F) resulted in a kinase dead receptor (Figure 4 , B and C) unable to induce loss of cell adhesion or ectopic posterior protrusions ( Figure 5C ), as anticipated from previous work showing that substitution of the juxtamembrane tyrosines with phenylalanine locks Eph receptors in an autoinhibited state (Wybenga-Grout et al., 2001) . Similarly, a kinase dead Y928FK653R double mutant was not tyrosine phosphorylated or kinase active and did not induce loss of cell adhesion or ectopic protrusions (Figures 4, B and C, and 5C) . To obtain an EphA4 mutant that retains kinase activity but is defective for binding to SH2 proteins, the juxtamembrane tyrosines were changed to glutamate. This substitution is anticipated to simulate juxtamembrane phosphorylation by maintaining a negative charge, thereby overcoming the inhibitory effects of the unphosphorylated juxtamembrane region. However, glutamate residues do not support binding to SH2 domains, and such a mutant should be compromised in its ability to recruit cytoplasmic targets to the juxtamembrane region. The Y928FY596/602E mutant was active as a kinase ( Figure 4C ) and induced ectopic protrusions ( Figure 5 , A and C), indicating that phosphotyrosinedependent binding of SH2 proteins to the juxtamembrane region is not necessary for induction of ectopic protrusions by the Y928F mutant. This mutant was not robustly tyrosine phosphorylated ( Figure 4B ), likely reflecting the loss of three major tyrosine phosphorylation sites. In contrast, the loss of cell adhesion observed in Y928F embryos during early embryogenesis was not observed in embryos expressing the Y928FY596/602E mutant receptor ( Figure  5B ). These data suggest that phosphorylation of the juxtamembrane tyrosines and potential recruitment of SH2 domain targets to these sites is necessary for Y928F-induced cell dissociation, and that de-adhesion is separable from formation of ectopic posterior structures.
To determine if Y928F-induced tyrosine phosphorylation is dependent on ligand binding, N-terminally Flag-tagged mutants lacking the globular ligand-binding domain were constructed ( Figure 4A ). The ⌬GD-Flag-Y928F mutant receptor displayed a high level of tyrosine phosphorylation in vivo ( Figure 4D ), demonstrating that signaling by microinjected EphA4 is ephrin independent. This may be due to activation of the Y928F receptor by overexpression or to compensating dimerization motifs in the extracellular domain of the receptor, whose activity may be enhanced in the absence of a functional SAM domain. Previous in vitro studies indicate that purified Y928F EphA4 SAM domain protein behaves like a dimer in solution (DS; unpublished data). To determine if SAM domain-mediated dimerization is required for activity of the Y928F mutant, an Y928FM972K double mutant was constructed ( Figure 4A ). Kinase activity and protrusion-induction are not affected by a mutation within the SAM dimerization interface (Y928FM972K; Stapleton et al., 1999) , suggesting that SAM dimerization is not essential for Y928F-induced activities (Figures 4, B and C, and 5, A and C).
Activated FGFR1 Induces Ectopic Posterior Protrusions with the Same Molecular Characteristics as Y928F
The phenotype of Xenopus embryos expressing the Y928F EphA4 receptor is similar to that of embryos expressing activated FGF receptor 1 (actFGFR1; Weinstein et al., 1998 ; Figure 6A ). In situ hybridizations were performed on Xenopus embryos expressing actFGFR1 to determine whether the molecular characteristics of the actFGFR1-induced posterior protrusions are the same as those induced by Y928F. The posterior markers Xpo, Xwnt3a, Xhox-3, the neural crest marker Xap-2, and FGF-8 ( Figure 6B ) were expressed in both the Y928F EphA4-induced protrusions and the ectopic protrusions of actFGFR1-expressing embryos. This suggested a connection between Eph and FGF signaling pathways. 
EphA4 Induces Expression of FGFs and Their Receptors
To pursue the relationship between Eph and FGF receptor signaling, the expression of FGF was examined in explants expressing the Y928F EphA4 mutant. Y928F EphA4 mRNA (1.5 ng/embryo) was injected into the animal pole of twocell stage embryos. Ectodermal animal caps were excised at stage 8 and cultured until stage 26. RT-PCR analysis revealed that eFGF and particularly FGF-8 were induced by Y928F EphA4 (Figure 7A ). To determine whether the induction eFGF and FGF-8 was an early event in response to Y928F EphA4 expression, explants were prepared from gastrula stage embryos injected with increasing doses of Y928F EphA4 RNA (0.125-0.5 ng). RT-PCR analysis demonstrated that eFGF was weakly induced, but a dose-dependent induction was not observed ( Figure 7B ). In contrast, FGF-8 was robustly induced in a dose-dependent manner, suggesting that FGF-8 induction is an early event and represents a tightly linked response to EphA4 activity in explant culture ( Figure 7B) .
Furthermore, whole mount in situ hybridizations of 1-day embryos revealed that FGF-8 was prominently expressed in the budding posterior structures of Y928F EphA4 embryos ( Figure 7C ), whereas eFGF was only weakly expressed (unpublished data). Because FGF ligand is present in the ectopic protrusions, the presence of possible cognate receptors was examined. Whole mount in situ hybridization indicated that Y928F embryos expressed both FGFR1 ( Figure 7C ) and FGFR4a ( Figure 7C ) in the budding posterior structures.
These results raise the possibility of a link between EphA4 and FGF signaling.
FGF-8 Is Involved in Activated EphA4-induced Posterior
Protrusions eFGF has been shown to induce mesoderm tissues during early Xenopus development (Kimelman and Kirschner, 1987; Slack et al., 1987) , but muscle actin (a late mesoderm marker) is not expressed in ectodermal explants or ectopic tails expressing Y928F (unpublished data). FGF-8, however, has been shown to induce neural differentiation through FGFR4a and inhibit mesoderm induction during Xenopus development (Hardcastle et al., 2000) . FGF-8 has the ability to induce posterior expansion and anterior reduction when overexpressed (Beck and Slack, 1998; Christen and Slack, 1999) . These data make FGF-8 a promising candidate for mediating EphA4 induced ectopic protrusion formation.
To test whether FGF-8 may participate in Y928F EphA4 signaling in the embryo, an FGF-8 loss-of-function approach was used. FGF-8a and FGF-8b cDNAs were isolated from a Xenopus stage 30 head library. The FGF-8a cDNA sequence is identical to the previously reported Xenopus FGF-8 sequence (Christen and Slack, 1999) . FGF-8b, however, has an additional 11 amino acids containing a glycosylation site in the N-terminal region (GenBank Accession number: AF484745). Antisense FGF-8 morpholino oligonucleotides (FGF-8-AS) and a control morpholino oligonucleotide containing four point mutations within the FGF-8-AS sequence (FGF-8-AS-4PM) were designed. The specificity of FGF-8-AS and FGF-8-AS-4PM were confirmed in vitro. Western blot analysis of in vitro-translated HA-tagged FGF-8 in the presence or absence of FGF-8-AS or FGF-8-AS-4PM demonstrates specific inhibition of FGF-8 translation by FGF-8-AS and not FGF-8-AS-4PM ( Figure 8A ). High concentrations of FGF-8-AS block gastrulation movements (unpublished data), a phenotype similar to that observed with the disruption of FGF-8 in mice (Sun et al., 1999) . To avoid this, the amount of FGF-8-AS was titered to a level that would not have a dramatic effect on development (14 ng/embryo), and this was used for future experiments (unpublished data). Coinjection of FGF-8-AS with Y928F EphA4 (2.5 ng/embryo) resulted in a substantial reduction in the incidence of ectopic posterior protrusion formation ( Figure 8B ). In contrast, injection of FGF-8-AS-4PM did not affect formation of these structures induced by Y928F ( Figure 8B ). These results are consistent with a causative role for FGF-8 in the phenotypic effects induced by Y928F in the embryo.
DISCUSSION
Eph RTKs are subject to complex regulation, involving interaction with cell-associated ephrins and subsequent receptor oligomerization, followed by receptor autophosphorylation at multiple regulatory tyrosines. Activated Eph receptors can potentially bind cytoplasmic targets through several motifs, including the juxtamembrane region, SAM domain, and C-terminal PDZ-binding sequence. We tested the contribution of specific tyrosines within the EphA4 juxtamembrane region and SAM domain using a Xenopus microinjection system to assess the biological activity of these highly conserved sites in Eph receptor signaling.
SAM domains have been proposed to mediate homotypic or heterotypic protein-protein interactions. Indeed, the SAM domains of EphA4 and EphB2 are able to form homotypic oligomers (Smalla et al., 1999; Stapleton et al., 1999; Thanos et al., 1999) . Here, we have found that the SAM domain of ectopically expressed EphA4 is not required for either activation of the receptor's tyrosine kinase domain or signaling that can elicit morphogenetic changes during Xenopus development (Figure 1 , B and C). Deletion of both the SAM and PDZ domains did not affect tyrosine phosphorylation and activation of EphA4 (Figure 1, B and C) . Similarly, substituting Phe for Tyr at position 928 within the SAM domain maintained EphA4 kinase activity and constitutive EphA4 tyrosine phosphorylation in vivo (Figure 1 , B and C). However, this mutation resulted in an observable increase in ectopic induction of posterior protrusions when compared with WT EphA4 (Figure 2B ), suggesting that tyrosine 928 may act, in part, to suppress EphA4 in vivo activity. We have no evidence to support an inhibitory effect of the Y928 site on EphA4 kinase activity. Alternatively, this site may bind a negative regulator that in turn suppresses kinase activity toward a specific substrate. Y929 in EphB1 corresponds to Y928 in EphA4 and has been identified as a potential binding site for LMW-PTP and/or Grb10 (Stein et al., 1996 (Stein et al., , 1998 . It is possible that the Y928F mutation may preclude binding of LMW-PTP or Grb10 and thus partially enhance EphA4 activity. Although we have no evidence indicating that LMW-PTP binds to EphA4 in Xenopus (our unpublished results and Park et al., 2002) , our data are consistent with the hypothesis that Y928 is a protein-protein interaction site for a negative regulator, which might be recruited upon phosphorylation of Y928 and serve to downregulate the receptor.
Most existing Eph mutations in invertebrates and mammals have led to a decrease or loss of receptor activity. Here we consider the phenotypic effects of EphA4 overexpression. Overexpression of either the WT or the Y928F EphA4 mutant causes a striking phenotype in which animal blastomeres lose cell adhesion in early Xenopus development ( Figure 3A ), but revert to apparently normal adherence at late gastrulation. As development proceeds, tail-like protrusions and severely expanded posterior structures are observed (Figure 3) . In situ hybridization analysis established the posterior character of these protrusions (Figures 2 and  3B) . Furthermore, Xap-2 staining reveals that Y928F disrupts patterning of the third and fourth branchial arches ( Figure  3B ). Although the second arch appears normal, the third and fourth branchial arches fuse and expand toward the posterior and ventral regions ( Figure 3B ). This is consistent with previous observations demonstrating that expression of a truncated EphA4 receptor disrupts the migration of cranial neural crest cells during Xenopus development (Xu et al., 1995; Smith et al., 1997) . It is possible that neural crest cells expressing activated EphA4 migrate abnormally, perhaps contributing to the protruding cell mass that forms the ectopic posterior structures. Supporting this concept, Y928F-induced ectopic protrusions express neural crest markers such as Xslug, Xap-2 ( Figure 3B ), and ADAM-13 (unpublished data; Alfandari et al., 1997) . The idea that neural crest migration rather than induction accounts for marker expression in the ectopic protrusions is supported by the observation that ectodermal explants expressing Y928F fail to induce neural or neural crest markers (our unpublished results). Alternatively, EphA4 may disrupt normal embryo patterning through its early effects on cell adhesion, resulting in an abnormal positioning of cells expressing neural and neural crest marker genes. This is unlikely because Y928FY596/ 602E induces ectopic protrusions, but not cell dissociation ( Figure 5 , A-C).
We have used the Y928F EphA4 mutant to test the functions of receptor kinase activity and autophosphorylation in the regulation of Xenopus cell adhesion and posterior structure formation. A mutation in the kinase domain that abrogates catalytic activity caused a loss of EphA4 Y928F biological activity. Similarly, conversion of juxtamembrane tyrosines 596/602 to phenylalanines, which locks EphA4 in an autoinhibited state through repressive interactions of the juxtamembrane region with the kinase domain, also blocked Y928F-induced phenotypes. Once phosphorylated, these same tyrosines, which lie in YXXP motifs, can serve as docking sites for SH2-containing proteins (reviewed in Kalo and Pasquale, 1999b; Boyd and Lackmann, 2001) . Substitution of the juxtamembrane tyrosines with glutamates, in the context of the Y928F EphA4 mutant, maintains constitutive kinase activity (because the introduction of negatively charged residues interferes with the inhibitory interaction between the juxtamembrane region and the kinase domain), but should block phosphotyrosine-dependent binding to SH2 proteins (Figure 4) . The Y596/602E substitutions block EphA4 Y928F-induced disruption of cell-cell adhesion, but not ectopic protrusion formation ( Figure 5 ). These data argue that interaction of the phosphorylated juxtamembrane tyrosines is important for signaling that leads to the loss of cell adhesion, but is not essential for ectopic posterior protrusion formation. Furthermore, these data indicate that these ectopic structures are not simply derived from disrupted patterning due to cell dissociation.
FGF signaling plays multiple roles during Xenopus development including mesoderm induction, posteriorization of neural tissue, and limb regeneration. Activated FGF receptor 1 (actFGFR1), like several FGF pathway elements (Pownall et al., 1996; Tada et al., 1997; Weinstein et al., 1998; Brewster et al., 2000; Hama et al., 2001) , induces ectopic protrusions in addition to anterior reduction and posterior expansion (Figure 6A ). Ectopic structures induced by actFGFR1 have molecular characteristics similar to those induced by activated EphA4 (Figure 6B and FGF signaling. An active EphA4 receptor induces eFGF and FGF-8 (both FGF-8a and FGF-8b) in early stage ectodermal explants ( Figure 7B ), and robust expression of FGF-8 as well as FGFR1 and R4a is found in developing ectopic posterior structures ( Figure 7C ). Although it is formally possible that eFGF plays a role in ectopic protrusion formation, we have no direct evidence that this is the case. eFGF is a strong mesoderm inducer (Kimelman and Kirschner, 1987; Slack et al., 1987) , but mesoderm tissue and markers were not evident in the ectopic structures or ectodermal explants expressing Y928F EphA4. Furthermore, the eFGF induction by Y928F EphA4 did not appear to be dose dependent, implying that the induction may not be direct. Supporting these data, eFGF antisense (AS) morpholino oligonucleotides have no observable effect on the Y928F EphA4-induced phenotypes (E-K.P. and I.O.D., unpublished results). Alternatively, expression of eFGF may be too weak to induce mesoderm tissue, but may still have an influence on the induction of ectopic protrusions.
In contrast, experiments using FGF-8 AS morpholino oligonucleotides result in a substantial reduction in the incidence of ectopic posterior structure formation ( Figure 8B ). We have also found that coexpression of WT FGFR1 and Y928F increases the incidence of these ectopic structures in embryos (E-K.P. and I.O.D., unpublished results), supporting a role for FGF in the formation of these posterior structures. Xenopus FGF-8 (XFGF-8) has been reported to induce ectopic neural tissue in Xenopus embryos (Hardcastle et al., 2000) , but does not increase proliferation of BaF3 cells expressing FGFR1c, suggesting FGF-8 may not bind to FGFR1 (MacArthur et al., 1995) . However, XFGF-8-induced ectopic neuralization is strongly inhibited by a dominant negative FGFR4a, and only weakly by a dominant negative FGFR1, suggesting that both receptors may be involved in this FGF-8 mediated event. Moreover, weak induction of mesoderm by XFGF-8 is blocked by dominant negative FGFR1, supporting involvement or utilization of FGFR1 by the FGF-8 ligand (Christen and Slack, 1999; Hardcastle et al., 2000) .
Previous studies in Xenopus used only the XFGF-8a isoform (Christen and Slack, 1999; Hardcastle et al., 2000) ; however, an XFGF-8b isoform was also isolated, which is the predominant isoform induced by the active EphA4 ( Figure  7 ). Unlike FGF-8a, the FGF-8b isoform is able to induce significant activation of MAPK when expressed during early Xenopus embryogenesis (E-K.P. and I.O.D., unpublished results), consistent with the possible use of FGFR1 or other FGF receptors that are expressed at this time (Robbie et al., 1995) . It is possible that activated EphA4 can induce another family of FGFs that activate FGFR1 directly or indirectly. Functional redundancy of the FGF family has been proposed in many studies including the knock-out of specific FGF isoforms (reviewed in Powers et al., 2000) . Regardless of whether one or more FGF receptors are involved, FGF signaling is clearly activated and, at least in part, necessary for the induction of ectopic protrusions by an active EphA4 receptor.
